NOVAVAX INC - NOTE 3.750% 2/0

Historical Holders from Q1 2017 to Q1 2023

Type / Class
Debt / NOTE 3.750% 2/0
All holders as of 31 Mar 2023
Q1 2023
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-25
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NOVAVAX INC - NOTE 3.750% 2/0

Period Principal Value Change Price Investors
2023 Q1 0 $0 -$320,115,312 0
2022 Q4 320,793,000 $320,115,312 -$5,314,032 $0.995 25
2022 Q3 317,882,137 $312,049,040 -$4,749,065 $0.9806 22
2022 Q2 321,740,000 $322,677,000 -$11,586,725 $1 21
2022 Q1 331,115,000 $353,701,452 -$8,147,757 $1.07 20
2021 Q4 331,205,000 $453,584,559 -$44,620,608 $1.37 26
2021 Q3 363,771,000 $632,669,875 +$5,047,837 $1.73 29
2021 Q2 356,835,000 $637,149,875 +$37,667,653 $1.79 25
2021 Q1 331,058,000 $548,276,360 +$40,019,901 $1.66 23
2020 Q4 335,633,000 $421,453,059 +$1,958,066 $1.25 24
2020 Q3 332,045,000 $397,351,117 +$24,391,221 $1.2 29
2020 Q2 319,093,000 $304,764,000 +$41,944,671 $0.9567 15
2020 Q1 275,414,000 $215,598,000 +$13,172,590 $0.786 12
2019 Q4 274,948,000 $109,765,000 -$56,432 $0.3965 16
2019 Q3 274,898,000 $115,391,000 -$5,550,192 $0.4175 17
2019 Q2 288,318,000 $115,081,000 -$2,062,252 $0.3938 17
2019 Q1 294,444,382 $107,322,508 -$13,954,689 $0.365 21
2018 Q4 308,563,000 $187,221,000 +$1,249,785 $0.6103 27
2018 Q3 309,463,000 $189,333,000 -$4,210,685 $0.6136 32
2018 Q2 318,105,000 $186,280,000 -$3,991,490 $0.5875 25
2018 Q1 325,540,000 $229,197,000 +$2,964,515 $0.7061 25
2017 Q4 322,058,000 $150,824,000 +$3,357,433 $0.4726 22
2017 Q3 315,058,000 $143,428,000 +$891,808 $0.4554 21
2017 Q2 314,008,000 $135,817,000 -$933,943 $0.4295 20
2017 Q1 315,714,000 $144,157,000 +$144,157,000 $0.4586 20